Skip to main content
Pangea Wellness Inc. logo

Pangea Wellness Inc. — Investor Relations & Filings

Ticker · PNGA ISIN · CA6979501039 CSE Manufacturing
Open in API
Filings indexed 244 across all filing types
Latest filing 2022-07-11 Regulatory Filings
Country CA Canada
Listing CSE PNGA

About Pangea Wellness Inc.

https://pangea-wellness.com/

Pangea Wellness Inc. is a North American manufacturer and distributor specializing in clean-label foods and innovative wellness products. The company focuses on creating high-quality, plant-based products that emphasize nutrition, sustainability, and convenience. Pangea Wellness operates through multiple brands, including its subsidiary, Amino Innovations, which develops science-backed wellness solutions. Amino Innovations specializes in advanced peptide therapies (such as BPC and Epitalon) delivered via accessible oral and topical systems, aiming to provide effective alternatives to traditional methods. Pangea Wellness products are distributed across North America, available online and in over 500 premium retail locations.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Regulatory Filings
2022-07-11 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Pangea Natural Foods Inc. has commenced trading on the Canadian Securities Exchange. It focuses on the company's business, product details, and forward-looking statements about growth and distribution. There is no financial data, no detailed report, no voting results, no management changes, no legal proceedings, or other specific regulatory filings. The document is an announcement of a listing event, which fits best under a general regulatory announcement category. It is not a full report or financial statement, nor is it a report publication announcement since it does not mention any report being published or attached. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-07-04 English
Filing statement - English.pdf
Regulatory Filings
2022-06-30 English
52-109FV2 - Certification of interim filings - CFO (E).PDF
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CFO of Pangea Natural Foods Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended April 30, 2022. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. It references an interim report but does not include the report itself. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report (IR). The document length is short (3019 characters), consistent with a certification letter rather than a full report.
2022-06-22 English
52-109FV2 - Certification of interim filings - CEO (E).PDF
Regulatory Filings Classification · 95% confidence The document is a certification by the CEO of Pangea Natural Foods Inc. regarding the interim financial report and interim MD&A for the period ended April 30, 2022. It is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate. The text does not contain actual financial data or analysis but is an attestation about the interim filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report itself (IR). The document length is short (3026 characters) and is primarily a certification letter, not the full interim report.
2022-06-22 English
Interim financial statements/report – English.PDF
Regulatory Filings
2022-06-22 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.